M&A Senior Associate, International Markets
Market Rate — Market Research Analysts and Marketing Specialists
25th
$53K
Median
$75K
75th
$102K
BLS 2024 data (national)
Description
Job Description Summary
This M&A senior associate will play a key role in supporting inorganic growth activity in International Markets, supporting on executing on Business Development transactions, including mergers and acquisitions, divestitures, equity investments, partnerships and/or alliances, and licensingtex
Job Description
Role Summary / Purpose
The Senior Associate, Business Development and M&A will play a key role in supporting inorganic growth activity in International Markets.
Essential Duties
- Supports People Leader in executing on Business Development transactions, including mergers and acquisitions, divestitures, equity investments, partnerships and/or alliances, and licensing
- Lead various workstreams of the transaction process, including structuring, valuation, due diligence, negotiation and closing
- Provide project management leadership and support for business development projects, including strategy roadmap, market analyses, business case development, post-integration value creation, etc.
- Work cross-functionally with assigned segments, function, and regional teams to execute to identify gaps in business unit portfolio, and define executable steps to position segment for accelerated growth
- Work with GE HealthCare leadership to manage communication and alignment with key internal stakeholders to support effective decision making and transaction approval processes
- Partners with other Associate(s) and contributes to shared learning and knowledge to improve tools, processes, and templates for business development projects
- Other duties as required to execute on GE HealthCare’s strategic goals
Required Qualifications
- Bachelor’s Degree in Finance, Economics, Business Administration, Accounting or similar
- Minimum 6 years of work experience in finance, private equity, investment banking, business or corporate development or related field
- Strong quantitative and analytical skills, especially in financial modelling
- Familiarity and/or experience with executing on M&A transactions
- Experience supporting or leading certain elements of the business development transaction process: structuring, valuation, due diligence, negotiation, contracting, closing
- Strong communication and interpersonal skills
- Strong command of English (oral and written)
Preferred Qualifications
- Healthcare industry experience
- Master’s in Business Administration, Finance or similar field
- Able to communicate effectively with high-level leadership
- Adaptable and flexible: Open to change in response to new information, different or unexpected circumstances, and/or work in ambiguous situations
- Experience working internationally (e.g., across time zones, cultures, nationalities, etc.)
- Experience leading a project team and executing on a project end-to-end
- Strong network in private equity and/or start up ecosystem
Similar Jobs
Explore related positions you might be interested in
Senior Business Development Director, Micronization
Catalent·Schorndorf, Germany; Dusseldorf, Germany; Eberbach, Germany·16h ago
Business DevelopmentRespiratory
Assoc Dir, Patient Advocacy & Strategic Partnerships
Takeda·Lexington, MA·16h ago
Business DevelopmentGastroenterology
Business Development Director, Pharma and Consumer Health
Catalent·Schorndorf, Germany; Dusseldorf, Germany; Eberbach, Germany·16h ago
Business DevelopmentOncology
Job Title
Director/Sr. Director, Business Development & Corporate Strategy
Dendreon·Minimum·2d ago
Business Development
Title
Director, Corporate Strategy & Market Intelligence
NorthStar Medical Technologies·2d ago
Business Development
Vice President, Medical Affairs
Latigo Biotherapeutics·San Francisco, California, United States·2d ago
Business Development
Like this job? Get alerts for similar ones
We'll notify you when matching roles are posted.
Business DevelopmentSGP04-01-Singapore-Metropolis
Pipeline
GE Optima/Discovery® MRI data of the liverN/A
Continuous MonitoringN/A
Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying SubjectN/A
single photon emission computed tomographyN/A
ABUSN/A